Barcelona, 18-20 March
Latest News
Upcoming Events
Amphista will be attending and/or presenting at the following conferences. If you would like to meet with us, please email info@amphista.com
San Diego, 5-10 April
Protein Degradation in Focus Symposium
Dundee, 19-22 May
Amphista Therapeutics announces new data demonstrating in vivo efficacy and CNS activity of its mechanistically differentiated targeted protein degraders
First demonstration of efficacy in disease-relevant in vivo models for an orally delivered bifunctional non-cereblon / non-VHL-based protein degrader Deep degradation of target protein is achieved in a rapid, sustained, and highly selective manner Successful achievement of efficient CNS delivery for multiple degraders and demonstration of significant degradation of target protein in the brain Cambridge, […]
Amphista Therapeutics Achieves First Milestone in Second Discovery Programme with Bristol Myers Squibb
Cambridge, UK, September 26th, 2023 – Amphista Therapeutics (“the Company” or “Amphista”), a leader in next generation targeted protein degradation (TPD) approaches, today announces it has achieved the first milestone in the second active discovery programme under its strategic collaboration and license agreement with Bristol Myers Squibb (NYSE: BMY), triggering a payment for achieving the […]
Amphista Therapeutics Appoints Dr. Giles Brown as Senior Vice President of Chemistry
Highly experienced medicinal chemist joins to further strengthen Amphista’s next generation TPD approach Cambridge, UK, June 26, 2023 – Amphista Therapeutics (“the Company” or “Amphista”), a leader in next generation targeted protein degradation (TPD) approaches, today announced that Giles Brown, PhD, has been appointed as Senior Vice President (SVP) of Chemistry with immediate effect. In […]